Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity

Citation
S. Ashkar et al., Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity, SCIENCE, 287(5454), 2000, pp. 860-864
Citations number
52
Categorie Soggetti
Multidisciplinary,Multidisciplinary,Multidisciplinary
Journal title
SCIENCE
ISSN journal
00368075 → ACNP
Volume
287
Issue
5454
Year of publication
2000
Pages
860 - 864
Database
ISI
SICI code
0036-8075(20000204)287:5454<860:E(AECO>2.0.ZU;2-M
Abstract
Cell-mediated (type-1) immunity is necessary for immune protection against most intracellular pathogens and, when excessive, can mediate organ-specifi c autoimmune destruction. Mice deficient in Eta-1 (also called osteopontin) gene expression have severely impaired type-1 immunity to viral infection [herpes simplex virus-type 1 (KOS strain)] and bacterial infection (Listeri a monocytogenes) and do not develop sarcoid-type granulomas. Interleukin-12 (IL-12) and interferon-gamma production is diminished, and IL-10 productio n is increased. A phosphorylation-dependent interaction between the amino-t erminal portion of Eta-1 and its integrin receptor stimulated IL-12 express ion, whereas a phosphorylation-independent interaction with CD44 inhibited IL-10 expression. These findings identify Eta-1 as a key cytokine that sets the stage for efficient type-1 immune responses through differential regul ation of macrophage IL-12 and IL-10 cytokine expression.